Pursuant to Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, Emcure Pharmaceuticals has informed that it enclosed the ‘Investor Presentation – June 2026’. The same is also available on the Company’s website: www.emcure.com.
The above information is a part of company’s filings submitted to BSE.